Medpace is a full-service clinical contract research organization (CRO) providing Phase I–IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. With a mission to accelerate the global development of safe and effective medical therapeutics, Medpace employs a disciplined and scientific approach across major therapeutic areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral, and anti-infective research. Headquartered in Cincinnati, Ohio, Medpace operates in over 40 countries with a workforce exceeding 5,000 professionals.